Yuxiang Yan

Insight into ponatinib resistance mechanisms in rhabdomyosarcoma caused by the mutations in FGFR4 tyrosine kinase using molecular modeling strategies.

Fuchuan Li, Yuepiao Cai, Zhiguo Liu, 2019, International journal of biological macromolecules.

Stepwise identification of potent antimicrobial peptides from human genome

Li Yan, Qi Lv, Hongqi Liu, 2013, Biosyst..

FAT1 Upregulates in Oral Squamous Cell Carcinoma and Promotes Cell Proliferation via Cell Cycle and DNA Repair

D. Zheng, Q. Ge, Youguang Lu, 2022, Frontiers in Oncology.

LncRNAs are Involved in the Process of Atherosclerosis at Diverse Levels.

H. Zou, Yongqiang Li, Yuxiang Yan, 2022, Arquivos brasileiros de cardiologia.

LncRNAs are Involved in the Process of Atherosclerosis at Diverse Levels.

H. Zou, Yongqiang Li, Yuxiang Yan, 2022, Arquivos brasileiros de cardiologia.

estrogen‐independent activation of the ER and cell‐cycle regulation by cyclin D‐CDK4/6, epigenetic pathways, heat shock protein 90 and an immunogenic pathway including cytotoxic T‐lymphocyte associated protein 4 and programmed cell death 1 ligand 1/2‐ programmed cell death 1

T. Zhao, Haoliang Zhou, Xianbo Zhang, 2020 .

The association between CD28 gene rs3116496 polymorphism and breast cancer risk in Chinese women

Xianbo Zhang, Yuxiang Yan, 2017, Bioscience reports.

BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro.

Qiuhui Yang, Zhaojun Wang, Xiangjian Zhang, 2022, Biochemical and Biophysical Research Communications - BBRC.